OUR EXPERTISE – YOUR SUCCESS

Helping you to realise your objectives

From start to successful completion

OUR PEOPLE

Klaus Manlik

Klaus Manlik

Managing Partner

More than 30 years experience in the pharmaceutical Industry

Ulrike Däxl

Ulrike Däxl

Managing Director Operations

Industry experience as a senior analyst for stock-listed pharmaceutical companies

Niek Stander

Niek Stander

Chief Commercial Officer

Experienced in pharmaceutical commercial, general management and financial leadership

Mathias Käsebier

Mathias Käsebier

Senior Director

Former executive of Boehringer Ingelheim – specialty in global OTC business and global nutritional supplements

OUR GLOBAL REACH

We are strong in Europe, Latin America and Emerging Markets and have an extensive global network

Proprietary Global Database

BANNERT MANLIK’s unique proprietary global database includes more than 22.000 companies and more than 50.000 individuals with public as well as non-public information:

  • Rx companies
  • OTC companies
  • Generic companies
  • Nutraceutical companies
  • Phyto companies
  • Biotech companies
  • CMO’s
  • CRO‘s
  • Private Equity
  • …and more

BANNERT MANLIK HEALTH CHECK PROCESS

Our Service Partner Network

Flexible outsourcing and payroll services

Recruitment of specialised roles

(GM, Sales/KAM, Medical, Market access etc.)

Interim managemnet provider

Banking relationships

Management of European Marketing

Authorisations and patent advice

Contract research and regulatory affairs

Contract manufacters

Market research

Why Bannert Manlik?

Working with a network

of consultants with significant industry experience

Proprietary global database

Access to companies and individuals

Solutions

designed for specific engagement

no generic templates

Multinational team

that is motivated,
result-oriented
and very efficient

Successfully

closed 600+ deals

Commitment:

from planning to execution

Finalise Strategy Implementation

Divestment of
a Colombian
Pharma Company

to a Spanish stock-listed
Pharma Company

Deal Size
25 mn USD

Divestment of a
global Gastro
brand

to a German
Pharma Company

Deal Size
250 mn USD

Divestment of
an European
antibiotic brand

to a Belgian
Pharma Company

Deal Size
40 mn USD

Divestment of a
global cardiovascular
brand

to a German
Pharma Company

Deal Size
200 mn USD

Divestment of
an European
OTC-brand

to a German
OTC Company

Deal Size
40 mn USD

Divestment of
a Mexican
Pharma Company

to a LatAm based
Pharma Company

Deal Size
60 mn USD

BANNERT MANLIK COMPANY HEALTH GENERATOR

OUR LATEST SUCCESS STORIES (DEAL EXAMPLES)

Final Strategy
pfeil
pfeil
pfeil
pfeil

Financial

Plan

Divestment

Plan

Acquistion

Plan

Optimisation

Plan

pfeil
pfeil
pfeil
pfeil
Allocation of Responsibility for Strategy

About

Bannert Manlik Consultants

Since 1991, BANNERT MANLIK is one of the leading international strategic consulting fi rms for the pharmaceutical and healthcare industries.
We assist our clients throughout the entire M&A process, provide portfolio management strategies, as well as support in the realisation of international growth and other strategic goals.

CONTACT INFO

Our Office

Bannert-Manlik-Icon

Bannert Manlik Consultants GmbH
Maximilianstr. 4e

82319 Starnberg | Germany

Tel: + 49 . 8151. 973 65 0
info@bannert-manlik.com

Special newsletter

To support our clients in considering the effects of the COVID-19 crisis on their business, I will share over the next couple of weeks a number of newsletters on what companies should think about over the next few months to stabilize the company and to build for future success.

These newsletters are issued by Bannert-Manlik Consultants in association with Koru Financial Consulting.

KATEGORIEN

Covid 19 News inside